These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
263 related items for PubMed ID: 19563799
1. Pyruvate kinase isoenzyme M2 is a glycolytic sensor differentially regulating cell proliferation, cell size and apoptotic cell death dependent on glucose supply. Spoden GA, Rostek U, Lechner S, Mitterberger M, Mazurek S, Zwerschke W. Exp Cell Res; 2009 Oct 01; 315(16):2765-74. PubMed ID: 19563799 [Abstract] [Full Text] [Related]
2. Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells. Mazurek S. Int J Biochem Cell Biol; 2011 Jul 01; 43(7):969-80. PubMed ID: 20156581 [Abstract] [Full Text] [Related]
3. Isotype-specific inhibitors of the glycolytic key regulator pyruvate kinase subtype M2 moderately decelerate tumor cell proliferation. Spoden GA, Mazurek S, Morandell D, Bacher N, Ausserlechner MJ, Jansen-Dürr P, Eigenbrodt E, Zwerschke W. Int J Cancer; 2008 Jul 15; 123(2):312-321. PubMed ID: 18425820 [Abstract] [Full Text] [Related]
5. Pyruvate kinase type M2: a crossroad in the tumor metabolome. Mazurek S, Grimm H, Boschek CB, Vaupel P, Eigenbrodt E. Br J Nutr; 2002 Jan 15; 87 Suppl 1():S23-9. PubMed ID: 11895152 [Abstract] [Full Text] [Related]
6. Regulation of pyruvate kinase type M2 by A-Raf: a possible glycolytic stop or go mechanism. Mazurek S, Drexler HC, Troppmair J, Eigenbrodt E, Rapp UR. Anticancer Res; 2007 Jan 15; 27(6B):3963-71. PubMed ID: 18225557 [Abstract] [Full Text] [Related]
7. Nuclear translocation of the tumor marker pyruvate kinase M2 induces programmed cell death. Steták A, Veress R, Ovádi J, Csermely P, Kéri G, Ullrich A. Cancer Res; 2007 Feb 15; 67(4):1602-8. PubMed ID: 17308100 [Abstract] [Full Text] [Related]
8. Glycolytic inhibition by mutation of pyruvate kinase gene increases oxidative stress and causes apoptosis of a pyruvate kinase deficient cell line. Aisaki K, Aizawa S, Fujii H, Kanno J, Kanno H. Exp Hematol; 2007 Aug 15; 35(8):1190-200. PubMed ID: 17662887 [Abstract] [Full Text] [Related]
9. Effects of the human papilloma virus HPV-16 E7 oncoprotein on glycolysis and glutaminolysis: role of pyruvate kinase type M2 and the glycolytic-enzyme complex. Mazurek S, Zwerschke W, Jansen-Dürr P, Eigenbrodt E. Biochem J; 2001 May 15; 356(Pt 1):247-56. PubMed ID: 11336658 [Abstract] [Full Text] [Related]
10. Tumor-specific pyruvate kinase isoenzyme M2 involved in biochemical strategy of energy generation in neoplastic cells. Gumińska M, Ignacak J, Kedryna T, Stachurska MB. Acta Biochim Pol; 1997 May 15; 44(4):711-24. PubMed ID: 9584851 [Abstract] [Full Text] [Related]
11. Metabolic cooperation between different oncogenes during cell transformation: interaction between activated ras and HPV-16 E7. Mazurek S, Zwerschke W, Jansen-Dürr P, Eigenbrodt E. Oncogene; 2001 Oct 18; 20(47):6891-8. PubMed ID: 11687968 [Abstract] [Full Text] [Related]
12. Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells. Eigenbrodt E, Reinacher M, Scheefers-Borchel U, Scheefers H, Friis R. Crit Rev Oncog; 1992 Oct 18; 3(1-2):91-115. PubMed ID: 1532331 [Abstract] [Full Text] [Related]
13. Death-associated protein kinase increases glycolytic rate through binding and activation of pyruvate kinase. Mor I, Carlessi R, Ast T, Feinstein E, Kimchi A. Oncogene; 2012 Feb 09; 31(6):683-93. PubMed ID: 21725354 [Abstract] [Full Text] [Related]
14. Quantification of tumor type M2 pyruvate kinase (Tu M2-PK) in human carcinomas. Eigenbrodt E, Basenau D, Holthusen S, Mazurek S, Fischer G. Anticancer Res; 1997 Feb 09; 17(4B):3153-6. PubMed ID: 9329624 [Abstract] [Full Text] [Related]
15. [Pyruvate kinase (PK) isozyme switching and genetic heterogeneity of PK deficiency]. Kanno H. Nihon Rinsho; 1995 May 09; 53(5):1213-20. PubMed ID: 7602781 [Abstract] [Full Text] [Related]
16. Glycolysis in Plasmodium falciparum results in modulation of host enzyme activities. Mehta M, Sonawat HM, Sharma S. J Vector Borne Dis; 2006 Sep 09; 43(3):95-103. PubMed ID: 17024857 [Abstract] [Full Text] [Related]
17. Mitochondria, hexokinase and pyruvate kinase isozymes in the aerobic glycolysis of tumor cells. Petrucci D, Cesare P, Colafarina S. Ital J Biochem; 1997 Sep 09; 46(3):131-41. PubMed ID: 9442422 [Abstract] [Full Text] [Related]
18. Pyruvate kinase type M2: a key regulator within the tumour metabolome and a tool for metabolic profiling of tumours. Mazurek S. Ernst Schering Found Symp Proc; 2007 Sep 09; (4):99-124. PubMed ID: 18811055 [Abstract] [Full Text] [Related]
19. Different involvement for aldolase isoenzymes in kidney glucose metabolism: aldolase B but not aldolase A colocalizes and forms a complex with FBPase. Yañez AJ, Ludwig HC, Bertinat R, Spichiger C, Gatica R, Berlien G, Leon O, Brito M, Concha II, Slebe JC. J Cell Physiol; 2005 Mar 09; 202(3):743-53. PubMed ID: 15389646 [Abstract] [Full Text] [Related]
20. In vitro inhibitory effect of chitosan and its degradation products on energy metabolism in Ehrlich ascites tumour cells (EAT). Gumińska M, Ignacak J, Wójcik E. Pol J Pharmacol; 1996 Mar 09; 48(5):495-501. PubMed ID: 9112691 [Abstract] [Full Text] [Related] Page: [Next] [New Search]